Fig. 1From: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritisTotal ASES score at week 52 and week 104, stratified by treatment response profile. Response to treatment was associated with total scores on the Arthritis Self-Efficacy Scale (ASES) at week 52 and week 104, with more favourable responses to treatment resulting in stronger self-efficacy beliefs after both 1 and 2 years of treatmentBack to article page